$APTV

Agnevall Hakan purchased $199K of APTV

Agnevall Hakan purchased 4,100 shares of Aptiv PLC (APTV) at $48.58 ($0.20M total) on 2026-08-13.

Original reporting
SEC EDGAR · Agnevall Hakan
Published Aug 17, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$APTV
Neutral
medium confidence
Mentioned
$APTV
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$APTVNeutralLow
01

Why it matters

The newest fact is the director’s open-market purchase details (shares, price, total value, and holdings after).

02

Market read

Traders may note insider buying as a mild sentiment input, but there is no new operational or financial information about Aptiv.

03

What to watch

The article does not state whether the purchase was part of a broader pattern, nor does it provide context on prior holdings changes beyond the post-transaction share count.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-17, transaction dated 2026-08-13

Background

The article is a SEC Form 4 insider transaction disclosure for Aptiv PLC.

Company-level read

Ticker impact

$APTVNeutralMedium confidence
Context

Aptiv director Agnevall Hakan filed a Form 4 for an open-market purchase of 4,100 shares at $48.5810 on 2026-08-13.

Expected impact

Low near-term impact; any effect is likely modest and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a routine director open-market purchase with no 10b5-1 plan and no accompanying company-specific news in the text.

Market effects

No sector-level implications disclosed; only a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, compensation timing, or routine liquidity needs, so the signal may be weak.

Key entities

  • Aptiv PLC

    Subject of the Form 4 insider transaction disclosure.

  • Agnevall Hakan

    Director who purchased 4,100 shares open-market at $48.5810 on 2026-08-13.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$APTVHighAI 8/10

Aptiv (APTV) Turns Chip Partnerships Into A Physical AI Bet

Aptiv (APTV) will support NVIDIA's Jetson Orin Nano 2 processor, expanding their partnership. The company reported Q2 2026 revenue of $3.3B, up 2%, with adjusted EBITDA at $613M. Free cash flow declined to $12M from $219M a year earlier, with negative free cash flow of $196M for the first half of 2026. Aptiv is focusing on physical AI and robotics, while legacy automotive demand poses a headwind.

$APTVMed

Powered Driver Assistance to Europe

Axera (0600.HK) announced its M57 SoC powers Aptiv's new ADAS unit, now in mass production for a Chinese NEV automaker's EU-bound models. The solution meets 2026 Euro NCAP five-star requirements, reducing hardware size and power use by 20%. Axera's GM highlighted M57's global market readiness and compliance with safety standards.

$BBMed

BlackBerry vs. Aptiv: Which Auto Tech Stock Is the Better Buy?

BlackBerry (BB) and Aptiv (APTV) are both involved in automotive tech. BB's QNX segment saw Q1 FY2027 revenue rise 26% to $72M, with strong margins. APTV reported $5B in new business awards but cut 2026 revenue guidance. BB's stock is up 120% YTD, while APTV is down 35.8%. Analysts have lowered earnings estimates for both.

$APTVHighAI 9/10

Aptiv (APTV) Q2 2026 Earnings Call Transcript

Aptiv PLC (APTV) reported Q2 2026 net sales of $3.3 billion (+2% YoY) and adjusted EPS of $1.63 (+24%). Adjusted EBITDA was $613 million (18.7% margin). The company lowered full-year 2026 revenue guidance to $12.6 billion to $12.8 billion and adjusted EPS to $5.60 to $5.80 due to China weakness and program delays, while targeting $625 million to $725 million free cash flow.